PainReform Limited (PRFX) Company Long-Term Loans and Borrowings

PainReform Limited - graphic logo of issuer PRFX

PainReform Ltd. (PRFX) protects its positions with patents for the Plex03 system for managing postoperative pain, operating under the strictest FDA oversight. Slow-release technology allows the company to maintain pricing power for its services provided to clinics. The share price retrospective with the 0.00 indicator confirms the current status of the business. The absence of commercial products and reliance on investment make future growth hostage to the results of clinical trials.

PRFX PainReform Ltd.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for PainReform Limited (PRFX)

- price and consensus price forecast:
Stock Price painreform.com|PRFX - Price Target Chart
- market capitalization data:
Market Value PainReform|PRFX - Total Company Value
- book capitalization data:
Accounting Value per Share PainReform|PRFX - Book Capitalization|Market Capitalization to Book Value Ratio painreform.com|PRFX - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio PainReform Ltd.|PRFX - Long-Term Debt to Equity|Current Liabilities to Capital PainReform Corp|PRFX - Company Total Debt|Debt to Book Capital PainReform|PRFX - Company Long-Term Debts|Company Short-Term Loans and Borrowings PainReform
Fundamental company analysis:PRFX (painreform.com)
Manufactured products of PainReform

Long-term debt reflects the aggregate of obligations with a maturity exceeding one year, determining the issuer's financial stability. An increase in this metric signals a rising debt load and potential loan servicing costs. By analyzing the long-term debt indicator, an investor assesses the default risk should the cost of capital change. For PainReform Ltd. (PRFX), this trend is critical due to the vulnerability of raw material supply chains. Geopolitical barriers could restrict liquidity, complicating the fulfillment of long-term obligations.

Analysis of competing companies

haleon.com - Company Long-Term Debts|Company Long-Term Debt Kenvue (KVUE)|VRNA: Company Long-Term Loans and Borrowings|MENS (Jyong Biotech Corp) - Company Long-Term Debt|Ligand Corp (LGND) - Company Long-Term Liabilities|AMRX (Amneal Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts perrigo.com (PRGO)|Alvotech SA (ALVO) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings LQDA (Liquidia Corp)|GLPG: Company Long-Term Debt|ANIP - Long-Term Debt|Company Long-Term Liabilities MannKind Corporation MNKD|AMPH - Amount of Long-Term Liabilities|Company Long-Term Debts Pacira BioSciences, Inc. PCRX|ARS Pharmaceuticals Inc (SPRY) - Company Long-Term Loans and Borrowings|Company Long-Term Debts TBPH (Theravance)|Long-Term Debt AQST|scPharmaceuticals Inc. (SCPH) - Company Long-Term Debt|Company Long-Term Loans and Borrowings TECX (tectonictx.com)|Tonix Pharmaceuticals Holding Corp. (TNXP) - Company Long-Term Debt|Long-Term Liabilities SXT Pharmaceuticals SXTC|Eupraxia Pharma - Company Long-Term Debts|BHST - Company Long-Term Debts|eXoZymes Inc - Company Long-Term Debts|ORMP (Oramed Pharmaceuticals Inc.) - Long-Term Debt Volume|Company Long-Term Debt Entera Bio Ltd (ENTX)|Company Long-Term Indebtedness HYFT|ABVC BioPharma Inc (ABVC) - Company Long-Term Debt|Company Long-Term Loans and Borrowings Cumberland Corp (CPIX)|QNTM: Company Long-Term Debts|Long-Term Debt fibrogen.com FGEN|Company Long-Term Debts Telomir Pharmaceuticals, Inc.|RANI: Long-Term Liabilities|Company Long-Term Debt SNYR|RLYB (Rallybio) - Long-Term Debt|LEXX - Company Long-Term Debt|Company Long-Term Loans and Borrowings PULM|Company Long-Term Debt PTHL (Pheton Holdings Ltd)|Company Long-Term Liabilities aptorumgroup.com APM|Company Long-Term Liabilities Lyra Therapeutics, Inc|impactbiomedinc.com - Company Long-Term Loans and Borrowings|TNFA - Company Long-Term Debt|cbdMD, Inc. (YCBD) - Company Long-Term Debt|CYTO - Company Long-Term Liabilities|Lipella Pharmaceuticals Inc (LIPO) - Amount of Long-Term Liabilities|Company Long-Term Debts Optinose (OPTN)|Company Long-Term Indebtedness Pieris Pharma (PIRS)|PROC (Procaps Group S.A.) - Company Long-Term Liabilities|Long-Term Debt Volume PTPI (petrospharma.com)|Qilian International Holding (QLI) - Company Long-Term Debt|Acelyrin Inc. - Long-Term Liabilities|Company Long-Term Debt TFF Pharma (TFFP)